Antisense
April 16 Webcast
- Shareholder Presentation on ATL1103 -
View
Home
Key People
Company Information
Technology Overview
Investor Relations
Product Pipeline
Useful Links
Contact Us
Antisense Therapeutics Limited (ANP) is an Australian publicly traded pharmaceutical drug discovery and development company whose mission is to create, develop and commercialise novel antisense therapeutics.
Latest Announcements
07-05-2012
-
Funding for ATL1103 Phase II Trial and Pipeline Activities
16-04-2012
-
Media Release - Professor Cohen
03-04-2012
-
Shareholder Presentations on ATL1103 Project by Leading Expert
29-02-2012
-
Terms Sheet Agreement to further Develop ATL1102
+61 (3) 9827 8999
Send us a message
+ 61 (3) 9827 1166
Antisense Therapeutics Limited
Level 1, 10 Wallace Avenue
Toorak, Victoria, 3142
Australia